Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Astellas Pharma Net Income 2012-2024 | ALPMY

Astellas Pharma annual/quarterly net income history and growth rate from 2012 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Astellas Pharma net income for the quarter ending December 31, 2024 was $M, a 100% decline year-over-year.
  • Astellas Pharma net income for the twelve months ending December 31, 2024 was $0.674B, a 62.21% decline year-over-year.
  • Astellas Pharma annual net income for 2024 was $0.113B, a 84.77% decline from 2023.
  • Astellas Pharma annual net income for 2023 was $0.742B, a 27.04% decline from 2022.
  • Astellas Pharma annual net income for 2022 was $1.017B, a 6.35% decline from 2021.
  
Astellas Pharma Annual Net Income
(Millions of US $)
2024 $113
2023 $742
2022 $1,017
2021 $1,086
2020 $1,793
2019 $2,002
2018 $1,554
2017 $1,953
2016 $1,608
2015 $1,236
2014 $882
2013 $881
2012 $954
2011 $836
2010 $1,319
2009 $1,761
Astellas Pharma Quarterly Net Income
(Millions of US $)
2024-12-31
2024-06-30 $241
2023-06-30 $242
2022-06-30 $191
2021-06-30 $279
2020-06-30 $469
2019-06-30 $533
2018-06-30 $502
2017-06-30 $382
2016-09-30 $475
2016-06-30 $620
2016-03-31 $259
2015-12-31 $505
2015-09-30 $478
2015-06-30 $366
2015-03-31 $163
2014-12-31 $394
2014-09-30 $327
2014-06-30 $351
2014-03-31
2013-12-31
2013-09-30
2013-06-30 $223
2013-03-31
2012-12-31
2012-09-30
2012-06-30 $444
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.499B $11.108B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.367B 31.71
Zoetis (ZTS) United States $70.491B 26.59
Takeda Pharmaceutical (TAK) Japan $44.101B 9.76
Daiichi Sankyo, - (DSNKY) Japan $43.319B 26.40
Sandoz Group AG (SDZNY) Switzerland $20.649B 0.00
Merck (MKKGY) Germany $18.495B 16.56
Summit Therapeutics (SMMT) United States $17.006B 0.00
United Therapeutics (UTHR) United States $16.401B 16.13
Shionogi (SGIOY) Japan $12.349B 12.37
Neurocrine Biosciences (NBIX) United States $11.577B 35.29
Orion OYJ (ORINY) Finland $7.681B 21.59
Madrigal Pharmaceuticals (MDGL) United States $7.656B 0.00
Corcept Therapeutics (CORT) United States $6.820B 51.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.245B 0.00
Stevanato Group S.p.A (STVN) Italy $6.199B 40.14
Ionis Pharmaceuticals (IONS) United States $5.197B 0.00
Grifols, S.A (GRFS) Spain $5.177B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $4.044B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.418B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.630B 11.92
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.438B 14.57
Centessa Pharmaceuticals (CNTA) United Kingdom $2.208B 0.00
Hypermarcas (HYPMY) Brazil $2.185B 0.00
Soleno Therapeutics (SLNO) United States $2.045B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.945B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.755B 0.00
Evotec AG (EVO) Germany $1.581B 0.00
Dyne Therapeutics (DYN) United States $1.424B 0.00
Ardelyx (ARDX) United States $1.355B 0.00
Guardian Pharmacy Services (GRDN) United States $1.273B 0.00
Indivior (INDV) United States $1.240B 5.38
ARS Pharmaceuticals (SPRY) United States $1.145B 0.00
Ocular Therapeutix (OCUL) United States $1.140B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.121B 0.00
Xencor (XNCR) United States $1.105B 0.00
Harrow (HROW) United States $1.073B 0.00
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.24
Avadel Pharmaceuticals (AVDL) Ireland $0.816B 0.00
Bioventus (BVS) United States $0.807B 25.51
Cronos Group (CRON) Canada $0.742B 0.00
Relay Therapeutics (RLAY) United States $0.685B 0.00
Verve Therapeutics (VERV) United States $0.663B 0.00
USANA Health Sciences (USNA) United States $0.612B 11.34
Xeris Biopharma Holdings (XERS) United States $0.592B 0.00
OmniAb (OABI) United States $0.548B 0.00
Elite Pharmaceuticals (ELTP) United States $0.531B 0.00
KalVista Pharmaceuticals (KALV) United States $0.526B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.475B 0.00
Altimmune (ALT) United States $0.472B 0.00
Savara (SVRA) United States $0.462B 0.00
ProKidney (PROK) United States $0.443B 0.00
Siga Technologies (SIGA) United States $0.437B 5.10
Organogenesis (ORGO) United States $0.425B 0.00
Zevra Therapeutics (ZVRA) United States $0.418B 0.00
Akebia Therapeutics (AKBA) United States $0.417B 0.00
Aldeyra Therapeutics (ALDX) United States $0.400B 0.00
Oruka Therapeutics (ORKA) United States $0.395B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.367B 148.79
Esperion Therapeutics (ESPR) United States $0.365B 0.00
Tourmaline Bio (TRML) United States $0.317B 0.00
CytoDyn (CYDY) United States $0.306B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.304B 0.00
Aquestive Therapeutics (AQST) United States $0.279B 0.00
Korro Bio (KRRO) United States $0.268B 0.00
Heron Therapeutics (HRTX) United States $0.262B 0.00
Avita Medical (RCEL) United States $0.261B 0.00
Nature's Sunshine Products (NATR) United States $0.257B 15.31
Innate Pharma SA (IPHYF) France $0.243B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.241B 0.00
Inhibikase Therapeutics (IKT) United States $0.226B 0.00
Profound Medical (PROF) Canada $0.224B 0.00
4D Molecular Therapeutics (FDMT) United States $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.209B 0.00
MediWound (MDWD) Israel $0.201B 0.00
Lyell Immunopharma (LYEL) United States $0.193B 0.00
Nanobiotix S.A (NBTX) France $0.186B 0.00
Acrivon Therapeutics (ACRV) United States $0.182B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.179B 0.00
Nektar Therapeutics (NKTR) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.150B 0.00
Silence Therapeutics (SLN) United Kingdom $0.150B 0.00
Champions Oncology (CSBR) United States $0.145B 0.00
Inotiv (NOTV) United States $0.143B 0.00
Lexeo Therapeutics (LXEO) United States $0.133B 0.00
Cassava Sciences (SAVA) United States $0.130B 0.00
ElectroCore (ECOR) United States $0.126B 0.00
Telomir Pharmaceuticals (TELO) United States $0.124B 0.00
Achieve Life Sciences (ACHV) Canada $0.111B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Journey Medical (DERM) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Galectin Therapeutics (GALT) United States $0.092B 0.00
Metagenomi (MGX) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.084B 0.00
Regulus Therapeutics (RGLS) United States $0.083B 0.00
Nutriband (NTRB) United States $0.082B 0.00
Protara Therapeutics (TARA) United States $0.081B 0.00
Pyxis Oncology (PYXS) United States $0.081B 0.00
FibroGen (FGEN) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.25
Karyopharm Therapeutics (KPTI) United States $0.077B 0.00
Avalo Therapeutics (AVTX) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Mural Oncology (MURA) Ireland $0.072B 0.00
Fractyl Health (GUTS) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Century Therapeutics (IPSC) United States $0.064B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Dominari Holdings (DOMH) United States $0.063B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
AleAnna (ANNA) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
AlloVir (ALVR) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
Surrozen (SRZN) United States $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.031B 0.00
BioVie (BIVI) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Biomerica (BMRA) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00